Medical Marijuana, Inc. and its portfolio of companies were recently showcased on the open-source, community-owned social networking service, Minds.com.
For Medical Marijuana, Inc. (MJNA), the second quarter of 2017 generated the largest revenue quarter in the Company’s history. This marked revenue growth presents unique opportunities for investors seeking MMJ stocks that are currently undervalued, according to new coverage on the open-source, community-owned social networking platform, Minds.com.
In the article, syndicated writer Richard Cox points to Medical Marijuana, Inc.’s 230% gross revenue increase during the second quarter of 2017 compared to the second quarter of last year, and its 185% increase in gross revenue during the first half of 2017 compared to the same period the year prior as indicative of the Company’s growth and major upward trend. MJNA announced in August that its subsidiary KannawayTM – a network sales and marketing company specializing in hemp-based botanical products — had its largest-ever single month of revenue in June 2017 and its largest-ever sales quarter.
Medical Marijuana, Inc. is the first publicly traded cannabis company in the United States. Introduced to investors in March of 2009, Medical Marijuana, Inc.’s stock opportunities are currently being utilized by over 200,000 shareholders. Cox notes that the Company’s stocks still remain and are ideal for those who are seeking undervalued MMJ investing assets in a growing stock market.
Acknowledging MJNA’s wide diversity of financial assets and fund counterparts, and touting the Company as “one of the most strongly established names in the emerging cannabis industry,” the Minds.com article suggests that MJNA is uniquely poised to capitalize on the growing hemp-derived cannabidiol (CBD) market, which is expected to grow to $1 billion in the next three years. For MJNA investors, Cox suggests, the surging CBD market could lead to substantial returns.
For more, you can read the Minds.com article HERE.
Keep up with Medical Marijuana, Inc. and its portfolio of companies by visiting our news page.
